United Therapeutics Corporation

United Therapeutics is a biotech company dedicated to developing innovative therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary fibrosis (PF), and neuroblastoma. Distinctively, it operates as a public benefit corporation, focusing on both advancing pharmaceuticals and creating technologies to address organ shortages, aiming to transform the future of patient care in life-threatening conditions.